Select your country and go to Livisto webpage near you

Products

FLUNEX 50 mg/ml

Back
Anti-inflammatories
Solution for injection
Composition:

Flunixin (meglumine) 50 mg/ml

Cattle
Indications:

Adjunctive therapy in the treatment of bovine respiratory diseases, endotoxemia and acute mastitis.
Alleviation of acute inflammation and pain associated with musculoskeletal disorders.
Reduction of post-operative pain associated with dehorning in calves of less than 9 weeks.

Posology:

Intramuscular and Intravenous use.
2.2 mg flunixin/kg b.w. (corresponding to 2 ml/45 kg b.w.)/once daily. Repeat as necessary at 24-hour intervals for up to 3 consecutive days.
Reduction of post-operative pain associated with dehorning in calves less than 9 weeks: a sinlge IV administration, 15-20 minutes before the procedure.

Withdrawal period:

Meat and offal: 4 days (IV use); 31 days (IM use).
Milk: 24 hours (IV use); 36 hours (IM use). 

Pigs
Indications:

Adjunctive therapy in the treatment of swine respiratory disease.
Adjunctive treatment of postpartum dysgalactia (Mastitis-Metritis-Agalactia) syndrome in sows.
Alleviation of acute inflammation and pain associated with musculoskeletal disorders.
Reduction of post-operative pain following castration and tail docking in sucking piglets.

Posology:

Intramuscular use.
2.2 mg flunixin/kg b.w. (corresponding to 2 ml/45 kg b.w.) once daily for up to 3 consecutive days.  The injection volume should be limited to a maximum of 4 ml per injection site.
Reduction of post-operative pain following castration and tail docking in sucking piglets: A single administration, 15-30 minutes before the procedure.

Withdrawal period:

Meat and offal: 24 days.

Horses
Indications:

Alleviation of acute inflammation and pain associated with musculoskeletal disorders.
Alleviation of visceral pain associated with colic.
Adjunctive therapy of endotoxemia due to or as a result of post-surgical or medical conditions or diseases that result in impaired blood circulation in the gastrointestinal tract.
Reduction of pyrexia.

Posology:

Intravenous use.
Alleviation of acute inflammation and pain associated with musculoskeletal disorders and reduction of pyrexia: 1.1 mg flunixin/kg b.w. (corresponding to 1 ml/45 kg b.w.)/ once daily, for up to 5 days.
Alleviation of visceral pain associated with colic: 1.1 mg flunixin/kg b.w. (corresponding to 1 ml/45 kg b.w.). Repeat once or twice if colic recurs. 
Adjunctive therapy of endotoxemia due to or as a result of post-surgical or medical conditions or diseases that result in impaired blood circulation in the gastrointestinal tract: 0.25 mg flunixin/kg b.w./every 6-8 hours or 1.1 mg flunixin/kg b.w. /once daily for up to 5 consecutive days.

Withdrawal period:

Meat and offal: 5 days.
Not authorised for use in mares producing milk for human consumption.

Pack size:

Vial of 50 ml, 100 ml and 250 ml


Download data sheet

* The information in the data sheet may be different according to your country’s regulations. If you have any doubts regarding this product, do not hesitate on contacting us.


Back